Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RELIEF THERAPEUTICS Holding (RLFTF)
OTHER OTC:RLFTF
RELIEF THERAPEUTICS Holding (RLFTF) Stock Price & Analysis
292 Followers
RLFTF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $8.50
Previous Close$1.45
Volume579.00
Average Volume (3M)3.00K
Market Cap
$15.24M
Enterprise Value-$1.30M
Total Cash (Recent Filing)CHF19.24M
Total Debt (Recent Filing)CHF2.69M
Price to Earnings (P/E)N/A
Beta0.70
Next Earnings
Sep 19, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,018,501
10 Day Avg. Volume1,517
30 Day Avg. Volume2,995
Standard Deviation0.18
R-Squared0.13
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)-0.05
Price to Sales (P/S)1.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RLFTF FAQ
What was RELIEF THERAPEUTICS Holding’s price range in the past 12 months?
RELIEF THERAPEUTICS Holding lowest stock price was $0.01 and its highest was $8.50 in the past 12 months.
What is RELIEF THERAPEUTICS Holding’s market cap?
Currently, no data Available
When is RELIEF THERAPEUTICS Holding’s upcoming earnings report date?
RELIEF THERAPEUTICS Holding’s upcoming earnings report date is Sep 19, 2024 which is in 143 days.
How were RELIEF THERAPEUTICS Holding’s earnings last quarter?
Currently, no data Available
Is RELIEF THERAPEUTICS Holding overvalued?
According to Wall Street analysts RELIEF THERAPEUTICS Holding’s price is currently Overvalued.
Does RELIEF THERAPEUTICS Holding pay dividends?
RELIEF THERAPEUTICS Holding does not currently pay dividends.
What is RELIEF THERAPEUTICS Holding’s EPS estimate?
RELIEF THERAPEUTICS Holding’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RELIEF THERAPEUTICS Holding have?
Currently, no data Available
What happened to RELIEF THERAPEUTICS Holding’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RELIEF THERAPEUTICS Holding?
Currently, no hedge funds are holding shares in RLFTF
---
RELIEF THERAPEUTICS Holding Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
RELIEF THERAPEUTICS Holding
Relief Therapeutics Holding AG is a Switzerland based drug development company focusing on clinical stage projects, primarily developing drugs of natural human origin. It is engaged in its operations for diabetic complications and respiratory diseases. The company is focused on developing drug candidates namely, Aviptadil and Atexakin alfa. Aviptadil is a biologically active endogenous human peptide that possesses anti-proliferative, anti-inflammatory, and immune regulatory activities. Atexakin alfa is a low dosage formulation of interleukin-6 that exhibits functions in diverse tissues and organs. The group operates its functions in Switzerland.
---
Technical Analysis
---